TORONTO, Canada--(BUSINESS WIRE)--BioPharma Services, Inc. (BioPharma) is proud to announce that it has acquired key human resource assets along with a list of validated assays from Bioanalytical Laboratory Services (BLS). Over the past 3 years, BLS, led by Lab Director, Nicola Hughes, Ph.D., has built a leading bioanalytical research centre specializing in complex method development, method validation and the analysis of biological samples for pre-clinical and clinical drug trials (BA/BE studies). BLS assets will be combined with BioPharma’s existing Bioanalytical Lab to further expand and fortify its analytical services and become a global leader in clinical research.
"We are very proud to combine the best of BioPharma’s existing bioanalytical lab with the best of BLS. Under the scientific leadership of Dr. Hughes, the expanded lab at BioPharma will be able to immediately offer challenging and complex new assays while strengthening our Scientific R&D team. This is just one of a list of benefits associated with merging the assets of two great labs at BioPharma,” said Renzo DiCarlo, CEO at BioPharma Services, Inc.
Effective immediately, Dr. Hughes will be appointed to the BioPharma Executive Team as the Vice-President of Lab Operations. “I am extremely excited about my team joining the BioPharma team and believe together, by offering scientific excellence, high quality assays and our commitment to providing exceptional service to our clients, we are ideally suited for the early stage research market.”
With this news, existing BLS client projects will be honoured and completed as planned at the current BLS facility. Anna Taylor, Vice-President of Business Development reiterated, "We truly are a client centered organization driven by science and quality research. I am excited that we have this opportunity to share our expanded BA lab expertise and service for both past and future clients under this new team at BioPharma.”
The statements in this press release are solely expressed and made by BioPharma Services, Inc.
About BioPharma Services Inc.
BioPharma Services Inc. is a full-service Contract Research Organization (CRO) specializing in the conduct of Phase I/IIa and Bioequivalence clinical trials for international pharmaceutical companies worldwide. BioPharma has clinical facilities both in the USA and Canada with a total capacity of 250 beds with access to healthy volunteers, special populations and patients. Headquartered in Toronto, Canada, BioPharma’s comprehensive services also include Bioanalysis at our GLP Certified Laboratory, Scientific and Regulatory Affairs, Biostatistics and Safety Data Analysis, Medical Writing and Data Management.
About Bioanalytical Laboratory Services (“BLS”)
Bioanalytical Laboratory Services is a Contract Research Organization (“CRO”) that specializes in the development, validation and application of LC-MS/MS bioanalytical methods for pre-clinical, non-clinical, Phase 1, and BA/BE clinical trials. The business employs a team who service clinical CROs and generic drug manufactures from BLS’ Toronto based laboratory.
